berinert stungulyfs-/innrennslisstofn og leysir, lausn 500 a.e.
csl behring gmbh* - c1-hemill - stungulyfs-/innrennslisstofn og leysir, lausn - 500 a.e.
nebido stungulyf, lausn 1000 mg/ 4 ml
grünenthal gmbh* - testosterone - stungulyf, lausn - 1000 mg/ 4 ml
cefuroxim fresenius kabi stungulyfs-/innrennslisstofn, lausn 1500 mg
fresenius kabi ab - cefuroximum natríum - stungulyfs-/innrennslisstofn, lausn - 1500 mg
berinert stungulyfsstofn og leysir, lausn 1500 a.e.
csl behring gmbh* - c1-hemill - stungulyfsstofn og leysir, lausn - 1500 a.e.
biorphen stungulyf/innrennslislyf, lausn 0,1 mg/ml
sintetica gmbh - phenylephrinum hýdróklóríð - stungulyf/innrennslislyf, lausn - 0,1 mg/ml
cefuroxim fresenius kabi stungulyfs-/innrennslisstofn, lausn 750 mg
fresenius kabi ab - cefuroximum natríum - stungulyfs-/innrennslisstofn, lausn - 750 mg
remifentanil hameln stofn fyrir stungulyfs-/innrennslisþykkni, lausn 2 mg
hameln pharma gmbh - remifentanilum hýdróklóríð - stofn fyrir stungulyfs-/innrennslisþykkni, lausn - 2 mg
ephedrine sintetica stungulyf, lausn 50 mg/ml
sintetica gmbh - ephedrinum hýdróklóríð - stungulyf, lausn - 50 mg/ml
influvactetra (influvac tetra) stungulyf, dreifa í áfylltri sprautu 15/15/15/15 míkróg/skammt
viatris aps - b/phuket/3073/2013-líkur stofn (b/phuket/3073/2013, villigerð); a/victoria/2570/2019 (h1n1)pdm09 - líkur stofn (a/victoria/2570/2019, ivr-215); a/darwin/9/2021 (h3n2)- líkur stofn (a/darwin/9/2021, san-010); b/austria/1359417/2021-like strain (b/austria/1359417/2021, bvr-26) - stungulyf, dreifa í áfylltri sprautu - 15/15/15/15 míkróg/skammt
berinert stungulyfsstofn og leysir, lausn 2000 a.e.
csl behring gmbh* - c1-hemill - stungulyfsstofn og leysir, lausn - 2000 a.e.